Marc Duey Aprea Therapeutics, Inc. (APRE) insider trading activity

APRE Quotes by TradingView

Marc Duey is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 233,651 shares of APRE, which is worth approximately $855,162. The most recent transaction as insider was on Oct 18, 2024, when has been sold 6,462 shares (Common Stock) at a price of $4.58 per share, resulting in proceeds of $29,595. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 234K
11.3% 3M change
11.86% 12M change
Total Value Held $855,162

Marc Duey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 18 2024
SELL
Open market or private sale
$29,595 $4.58 p/Share
6,462 Reduced 2.69%
233,651 Common Stock
Oct 16 2024
BUY
Open market or private purchase
$131,700 $4.39 p/Share
30,000 Added 11.11%
240,113 Common Stock
Oct 14 2024
BUY
Open market or private purchase
$490 $2.58 p/Share
190 Added 0.09%
210,113 Common Stock
Jun 20 2024
BUY
Grant, award, or other acquisition
-
1,045 Added 0.5%
209,923 Common Stock
Aug 23 2023
BUY
Grant, award, or other acquisition
-
500 Added 0.24%
208,878 Common Stock
Aug 23 2022
BUY
Conversion of derivative security
-
4,009,690 Added 49.03%
4,167,589 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
5,995 Added 3.66%
157,899 Common Stock
MD

Marc Duey

Director
Boston, MA

Track Institutional and Insider Activities on APRE

Follow Aprea Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

News

Receive news related to Aprea Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APRE